Brazilian antibody will be used to create new cancer drug
Recepta Biopharma, a Brazilian company, has signed a licensing agreement with Mersana Therapeutics, under which the US-based company's technology will be used to produce a monoclonal antibody (mAb) that can be deployed for ...
Aug 10, 2015
0
11